Future therapies in melasma: What lies ahead?

Volume: 86, Issue: 1, Pages: 8 - 17
Published: Jan 1, 2020
Abstract
Melasma is a common, acquired, symmetrical hypermelanosis. It negatively impacts the patient's quality of life and responds poorly to treatment. Although earlier classified as epidermal and dermal, melasma is now thought to be a complex interaction between epidermal melanocytes, keratinocytes, dermal fibroblasts, mast cells, and vascular endothelial cells. Factors influencing melasma may include inflammation, reactive oxygen species, ultraviolet...
Paper Fields
Paper Details
Title
Future therapies in melasma: What lies ahead?
Published Date
Jan 1, 2020
Volume
86
Issue
1
Pages
8 - 17
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.